Overall, these results indicated that SP1 up-regulated TUG1, and consequently inhibited miR-421, increased KDM2A and activated the ERK pathway, thus promoting the tumorigenesis of CRC cells in vivo. The gene discussed is TUG1; the disease is colorectal carcinoma.